[1]
Mahadkar, N., Dhoot, D.S. and Barkate, H. 2022. Comparative real-world effectiveness and safety of super-bioavailable itraconazole 50 mg bd and 65 mg bd in the management of dermatophytosis. International Journal of Research in Dermatology. 8, 4 (Jun. 2022), 433–436. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20221567.